JP2025159730A5 - - Google Patents

Info

Publication number
JP2025159730A5
JP2025159730A5 JP2025114462A JP2025114462A JP2025159730A5 JP 2025159730 A5 JP2025159730 A5 JP 2025159730A5 JP 2025114462 A JP2025114462 A JP 2025114462A JP 2025114462 A JP2025114462 A JP 2025114462A JP 2025159730 A5 JP2025159730 A5 JP 2025159730A5
Authority
JP
Japan
Prior art keywords
seq
nucleotide sequence
nucleic acid
canine
set forth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025114462A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025159730A (ja
Filing date
Publication date
Priority claimed from JP2022502248A external-priority patent/JP7757271B2/ja
Application filed filed Critical
Publication of JP2025159730A publication Critical patent/JP2025159730A/ja
Publication of JP2025159730A5 publication Critical patent/JP2025159730A5/ja
Pending legal-status Critical Current

Links

JP2025114462A 2019-07-15 2025-07-07 イヌctla-4に対するイヌ化抗体 Pending JP2025159730A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201962874287P 2019-07-15 2019-07-15
US62/874,287 2019-07-15
US201962926047P 2019-10-25 2019-10-25
US62/926,047 2019-10-25
US202063048873P 2020-07-07 2020-07-07
US63/048,873 2020-07-07
JP2022502248A JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体
PCT/EP2020/069923 WO2021009187A1 (en) 2019-07-15 2020-07-15 Caninized antibodies against canine ctla-4

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022502248A Division JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体

Publications (2)

Publication Number Publication Date
JP2025159730A JP2025159730A (ja) 2025-10-21
JP2025159730A5 true JP2025159730A5 (cg-RX-API-DMAC7.html) 2025-12-04

Family

ID=71620454

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022502248A Active JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体
JP2025114462A Pending JP2025159730A (ja) 2019-07-15 2025-07-07 イヌctla-4に対するイヌ化抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022502248A Active JP7757271B2 (ja) 2019-07-15 2020-07-15 イヌctla-4に対するイヌ化抗体

Country Status (8)

Country Link
US (2) US12435143B2 (cg-RX-API-DMAC7.html)
EP (1) EP3999538A1 (cg-RX-API-DMAC7.html)
JP (2) JP7757271B2 (cg-RX-API-DMAC7.html)
CN (2) CN114174337B (cg-RX-API-DMAC7.html)
AU (1) AU2020312686B2 (cg-RX-API-DMAC7.html)
BR (1) BR112022000721A2 (cg-RX-API-DMAC7.html)
CA (1) CA3145345A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021009187A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4326324A4 (en) * 2021-04-21 2026-03-25 Univ Pennsylvania Canine Monoclonal Antibodies Against Canine Cytotoxic T Lymphocyte-Associated Protein 4 (CTLA-4)
US12263232B1 (en) * 2024-06-10 2025-04-01 Wyvern Pharmaceuticals Inc. Composition for regulating production of proteins

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4596556A (en) 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
GB2183662B (en) 1985-04-01 1989-01-25 Celltech Ltd Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
EP0281604B1 (en) 1986-09-02 1993-03-31 Enzon Labs Inc. Single polypeptide chain binding molecules
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4941880A (en) 1987-06-19 1990-07-17 Bioject, Inc. Pre-filled ampule and non-invasive hypodermic injection device assembly
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
WO1994025591A1 (en) 1993-04-29 1994-11-10 Unilever N.V. PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
GB9818110D0 (en) 1998-08-19 1998-10-14 Weston Medical Ltd Needleless injectors and other devices
US6096002A (en) 1998-11-18 2000-08-01 Bioject, Inc. NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method
ES2706547T3 (es) 1998-12-23 2019-03-29 Pfizer Anticuerpos monoclonales humanos para CTLA-4
EP2275540B1 (en) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
US7605238B2 (en) 1999-08-24 2009-10-20 Medarex, Inc. Human CTLA-4 antibodies and their uses
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
CA2469833C (en) 2001-12-21 2008-05-20 Idexx Laboratories, Inc. Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them
GB0903325D0 (en) 2009-02-26 2009-04-08 Univ Aberdeen Antibody molecules
GB201103955D0 (en) * 2011-03-09 2011-04-20 Antitope Ltd Antibodies
GB201114858D0 (en) 2011-08-29 2011-10-12 Nvip Pty Ltd Anti-nerve growth factor antibodies and methods of using the same
AU2014368453B2 (en) 2013-12-20 2020-04-16 Intervet International B.V. Caninized murine anti-canine PD-1 antibodies
ES2853823T3 (es) * 2014-09-30 2021-09-17 Intervet Int Bv Anticuerpos de PD-L1 que se unen a PD-L1 canino
US10106107B2 (en) 2014-11-13 2018-10-23 Mitsubishi Electric Corporation Waterproof type control unit and waterproof type control unit manufacturing method
WO2016183469A1 (en) * 2015-05-13 2016-11-17 Robert Kirken Anti-ctla-4 blockade
WO2017062615A2 (en) 2015-10-08 2017-04-13 Macrogenics, Inc. Combination therapy for the treatment of cancer
ES3014160T3 (en) 2015-12-18 2025-04-21 Intervet Int Bv Caninized human antibodies to human and canine il-4r alpha

Similar Documents

Publication Publication Date Title
JP2005516613A5 (cg-RX-API-DMAC7.html)
JPH0838176A (ja) 改良組換dna分子
US20200109197A1 (en) Recombinant antibody compositions and methods of use thereof
JP2007530435A5 (cg-RX-API-DMAC7.html)
WO2017035241A1 (en) Enhanced production of immunoglobulins
RU2018119366A (ru) Мыши с гуманизированной легкой цепью
EP0135532A1 (en) PROCESS FOR THE PRODUCTION AND SELECTIVE ISOLATION OF PROTEINS AND POLYPEPTIDES, THEIR EXPRESSION AND RECOMBINANT VECTOR AND FUSION PROTEINS THAT MAY FIX ON THE CONSTANT REGION OF IMMUNOGLOBULINS.
JP2021524275A5 (cg-RX-API-DMAC7.html)
CN104011074A (zh) 用于克隆和表达关联抗体可变区基因区段的快速方法
JP2004041218A5 (cg-RX-API-DMAC7.html)
JP2025090679A5 (cg-RX-API-DMAC7.html)
JP2025508050A5 (cg-RX-API-DMAC7.html)
JP2025081549A5 (cg-RX-API-DMAC7.html)
JP2023533217A5 (cg-RX-API-DMAC7.html)
JP2004528803A5 (cg-RX-API-DMAC7.html)
RU2002133470A (ru) Специфичные в отношении вируса бешенства нейтрализующие моноклональные антитела человека и нуклеиновые кислоты, и связанные с ними способы
CN119490589A (zh) 一种靶向Nectin-4的纳米抗体、嵌合抗原受体CAR及应用
CN114107352A (zh) 使用修饰的核酸表达多肽的方法
JP2024523166A5 (cg-RX-API-DMAC7.html)
CN101988049B (zh) 共表达小鼠膜型白细胞介素15和Rae-1ε的转基因细胞及其制备方法
JP7856785B2 (ja) 哺乳動物細胞における選択マーカーとしての細菌グルタミン合成酵素
CN108823208B (zh) 一种四环素诱导启动子及其制备方法和应用
WO2020216191A1 (zh) 制备噬菌体文库的方法
JP2002542825A5 (cg-RX-API-DMAC7.html)
KR100597316B1 (ko) 클로렐라 바이러스 유래 신규 프로모터 및 그 용도